Sever Clint 4

4 · Cue Health Inc. · Filed Dec 7, 2022

Form 4

Period: 2022-12-05

Chief Product Officer

Transactions

Tax Payment
Common Stock
2022-12-05$3.05/sh−10,633$32,431→ 3,939,647 total
Exercise/Conversion
Common Stock
2022-12-06$0.20/sh+26,664$5,333→ 3,966,311 total
Exercise/Conversion
Common Stock
2022-12-07$0.20/sh+24,147$4,829→ 3,963,794 total
Sale
Common Stock
2022-12-06$3.14/sh−26,664$83,725→ 3,939,647 total
Sale
Common Stock
2022-12-07$2.98/sh−24,147$71,958→ 3,939,647 total
Exercise/Conversion
Employee Stock Option (right to buy)
2022-12-06−26,664→ 53,416 total
Exercise: $0.20Exp: 2022-12-31→ Common Stock (26,664 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2022-12-07−24,147→ 29,269 total
Exercise: $0.20Exp: 2022-12-31→ Common Stock (24,147 underlying)

Footnotes (6)

[F1]The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.
[F2]Includes 877,772 unvested RSUs.
[F3]The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.03 to $3.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.91 to $3.04, inclusive.
[F6]Shares subject to the option are fully vested and immediately exercisable.

Documents

1 file